Insider Transactions in Q1 2022 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Nicolas Barthelemy Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,000
+2.66%
|
$15,000
$3.43 P/Share
|
|
Feb 22
2022
|
Stephen Christopher Linthwaite President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,465
-3.66%
|
$37,395
$3.62 P/Share
|
|
Feb 22
2022
|
Stephen Christopher Linthwaite President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,417
+2.19%
|
-
|
|
Feb 22
2022
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,825
-2.06%
|
$8,475
$3.62 P/Share
|
|
Feb 22
2022
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,879
+1.67%
|
-
|
|
Feb 22
2022
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,269
-2.68%
|
$6,807
$3.62 P/Share
|
|
Feb 22
2022
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,062
+4.58%
|
-
|
|
Feb 22
2022
|
Colin Mc Cracken Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,740
-5.43%
|
$11,220
$3.62 P/Share
|
|
Feb 22
2022
|
Colin Mc Cracken Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,520
+3.15%
|
-
|
|
Feb 22
2022
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,184
-3.37%
|
$9,552
$3.62 P/Share
|
|
Feb 22
2022
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,753
+2.73%
|
-
|